Aphios® Corporation has been self-funded to date with Founders' capital, employee stock ownership, grants and contracts from the National Institutes of Health and other institutions, collaborative and contract research with emerging biotechnology and multinational companies, and product sales to biotechnology companies and research chemical distribution houses, such as Sigma-Aldrich.

We are actively seeking individual, high net worth and institutional investors as well as collaborations with strategic corporate partners to further the development of our enabling technology platforms and enhanced therapeutic products on a project or company basis. We plan to, individually or collectively:

If you are interested in being an investor, please fill out the form below. We will contact you shortly.

First Name: *
Please enter your First Name.
Last Name: *
Enter your Last Name.
Invalid Input
Email: *
Enter a valid Email Address.
Invalid Input
Invalid Input


Interested in learning more? Request this presentation.